Literature DB >> 27520518

Clinical Features and Drug Treatment of Psychodermatological Disorders.

M Van Moffaert1.   

Abstract

The skin is intricately involved with emotional and behavioural problems, both in a causative and a reactive way. This can lead to the development of psychodermatological disorders. In addition to its primary role of tactile receptivity, the skin reacts directly to emotional stimuli. The high visibility of dermatoses makes the skin a direct target for behavioural problems. Furthermore, self-destructive tendencies (such as dermatitis artefacta) and hypochondriacal features are often expressed through dermatological symptoms.In view of the clinical interface between dermatology and psychiatry, a combination of pharmacological and non pharmacological (psychotherapeutic and behavioural) therapies is recommended for the treatment of psychodermatological disorders. Psychotropic drug treatments that may be useful include benzodiazepines, antidepressants and antipsychotics.

Entities:  

Year:  1994        PMID: 27520518     DOI: 10.2165/00023210-199401030-00004

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  20 in total

1.  Diseases of the skin. Infantile eczema.

Authors:  G W Beveridge
Journal:  Br Med J       Date:  1974-01-26

2.  Dysmorphophobia.

Authors:  G G Hay
Journal:  Br J Psychiatry       Date:  1970-04       Impact factor: 9.319

3.  Delusions of infestation: treatment by depot injections of neuroleptics.

Authors:  A Frithz
Journal:  Clin Exp Dermatol       Date:  1979-12       Impact factor: 3.470

Review 4.  Psychosomatics for the practising dermatologist.

Authors:  M Van Moffaert
Journal:  Dermatologica       Date:  1982-08

5.  Antipruritic effect of an opiate antagonist, naloxone hydrochloride.

Authors:  J E Bernstein; R M Swift; K Soltani; A L Lorincz
Journal:  J Invest Dermatol       Date:  1982-01       Impact factor: 8.551

6.  Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure.

Authors:  B B Arnetz; B Fjellner; P Eneroth; A Kallner
Journal:  Psychosom Med       Date:  1985 Nov-Dec       Impact factor: 4.312

7.  Skin conductance conditioning with dyshidrotic eczema patients.

Authors:  R M Miller; R W Coger
Journal:  Br J Dermatol       Date:  1979-10       Impact factor: 9.302

8.  Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image.

Authors:  J A Cotterill
Journal:  Br J Dermatol       Date:  1981-06       Impact factor: 9.302

9.  Naloxone and self-mutilation.

Authors:  J S Richardson; W A Zaleski
Journal:  Biol Psychiatry       Date:  1983-01       Impact factor: 13.382

Review 10.  Dermatopsychosomatics: classification, physiology, and therapeutic approaches.

Authors:  R S Medansky; R M Handler
Journal:  J Am Acad Dermatol       Date:  1981-08       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.